Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

ImmuPharma Shares News & Articles

News in brief: Fevertree Drinks, Lakehouse, Gateley, Non-Standard Finance, ImmuPharma, Osirium Technologies

Fevertree goes for the double Analysts have once again upgraded earnings forecasts for Fevertree Drinks (FEVR) following another bullish trading update. Investec lifts its 2016 pre-tax profit estimate by 9% to £26.5 million. That is essentially twice the amount it originally forecast Fevertree to make this year (£13.9 million) when initiating coverage on the stock in January ...
Showing 1 to 20 of 28